MV Oil Trust(MVO) - 2024 Q4 - Annual Results
2025-01-06 21:15
Quarterly Distribution Announcement - MV Oil Trust announced the quarterly distribution for the payment period ended December 31, 2024[5] - The press release regarding the quarterly distribution was issued on January 6, 2025[5] Press Release Details - The press release is furnished as Exhibit 99.1 and incorporated by reference[5] - The press release is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934[6] - The press release is not subject to the liabilities of Section 18 of the Exchange Act[6] - The press release is not deemed incorporated by reference in any filing by MV Oil Trust under the Exchange Act or the Securities Act of 1933[6] - The press release is "furnished" for purposes of General Instruction B.2 of Form 8-K[6] Report Filing and Signatory - The report was signed by Elaina C. Rodgers, Vice President of The Bank of New York Mellon Trust Company, N.A., as Trustee[10] - The report was filed on January 6, 2025[10] Trading Information - MV Oil Trust's units of beneficial interest are traded on the New York Stock Exchange under the symbol MVO[3]
Golub Capital(GBDC) - 2025 Q1 - Quarterly Results
2025-01-06 21:14
Financial Results Announcement - Golub Capital BDC, Inc. will release its financial results for the quarter ended December 31, 2024 on February 4, 2025 [4] - The press release announcing the financial results is attached as Exhibit 99.1 [4] - The report includes Exhibit 99.1, which is the press release dated January 6, 2025 [6] Regulatory and Filing Information - The information in Item 2.02 of the Current Report on Form 8-K is being furnished and shall not be deemed "filed" for any purpose of Section 18 of the Securities Exchange Act of 1934 [5] - The information in the Current Report on Form 8-K shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing [5] - The report also includes a Cover Page Interactive Data File embedded within the Inline XBRL document [6] Report Details and Signatory - The report is signed by Christopher C. Ericson, Chief Financial Officer of Golub Capital BDC, Inc. [10] - The report is dated January 6, 2025 [10]
BP Prudhoe Bay Royalty Trust(BPT) - 2024 Q4 - Annual Results
2025-01-06 21:10
Termination of BP Prudhoe Bay Royalty Trust - BP Prudhoe Bay Royalty Trust did not receive a royalty payment for the quarter ended December 31, 2024, and will not make a quarterly cash distribution to unitholders[5] - The Trust terminated at 11:59 PM on December 31, 2024, due to no revenue received for any of the four quarters of 2023 or 2024[5] - The Trust terminated as per the Trust Agreement when net revenues from the Royalty Interest were less than $1.0 million per year for two successive years[12] NYSE Delisting and Compliance Issues - The Trust received a delisting notice from NYSE as the average closing price of its units was less than $1.00 over 30 consecutive trading days[6] - The Trust must regain compliance with NYSE listing standards within six months by achieving a closing unit price of at least $1.00 and an average closing unit price of at least $1.00 over 30 trading days[7] - The Trust has no control over the trading price of its units and cannot take actions like a reverse split without unitholder approval[8] Potential Impact of Delisting - If delisted, the Trust's units may be transferred to the over-the-counter market, potentially affecting market price, trading volume, liquidity, and resale price[10]
Serina Therapeutics, Inc.(SER) - 2024 Q4 - Annual Results
2025-01-06 21:07
POZ Platform® Enabling Improvements of Multiple Drug Modali Small Molecules New / improved small molecule drugs RNA Optimized targeting & reduced immunogenicity Impro cance serina Forward Looking Statements This presentation contains forward-looking statements that are based on management's beliefs and assumptions and on informatic to management. In some cases, you can identify forward-looking statements by the following words: "may, " will," "could," "would," ", "intend," "plan," "anticipate," "believe," " ...
AgeX Therapeutics(AGE) - 2024 Q4 - Annual Results
2025-01-06 21:07
POZ Platform® Enabling Improvements of Multiple Drug Modali Small Molecules New / improved small molecule drugs RNA Optimized targeting & reduced immunogenicity Impro cance serina Forward Looking Statements This presentation contains forward-looking statements that are based on management's beliefs and assumptions and on informatic to management. In some cases, you can identify forward-looking statements by the following words: "may, " will," "could," "would," ", "intend," "plan," "anticipate," "believe," " ...
MillerKnoll(MLKN) - 2025 Q2 - Quarterly Report
2025-01-06 21:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-15141 __________________________________________ MillerKnoll, Inc. (Exact name of ...
AbbVie(ABBV) - 2024 Q4 - Annual Results
2025-01-06 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2025 ABBVIE INC. (Exact name of registrant as specified in its charter) (State or other Jurisdiction (Commission File Number) (IRS Employer Delaware 001-35565 32-0375147 of Incorporation) Identification No.) 1 North Waukegan Road ...
CMC(CMC) - 2025 Q1 - Quarterly Report
2025-01-06 18:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ___________________________________ FORM 10-Q ___________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-4304 ___________________________________ COMMERCIAL METALS COMPANY ...
Bogota Financial (BSBK) - 2024 Q4 - Annual Results
2025-01-06 15:04
Exhibit 10.1 Execution Version AGREEMENT FOR PURCHASE AND SALE OF PROPERTY THIS AGREEMENT is made and entered into as of the Effective Date (as hereinafter defined), by and between BOGOTA SAVINGS BANK, a New Jersey corporation ("Seller" and "Leaseback Tenant"), and MOUNTAINSEED REAL ESTATE SERVICES, LLC, a Georgia limited liability company ("Buyer"). A. Seller is the owner of each Property (as hereinafter defined). B. Buyer wishes to purchase, and Seller wishes to sell, the Property, upon the terms and cond ...
Outset Medical(OM) - 2024 Q4 - Annual Results
2025-01-06 14:36
Exhibit 10.4 CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT HAS BEEN OMITTED BY MEANS OF REDACTING A PORTION OF THE TEXT AND REPLACING IT WITH [***] BECAUSE IT IS BOTH: (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version CREDIT AGREEMENT AND GUARANTY dated as of January 3, 2025 by and among OUTSET MEDICAL, INC. as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, THE LENDERS FROM TIME TO TIME PARTY HERETO, and PERCEPTIVE CREDIT HOL ...